«Heart palpitations. Shortness of breath. Dizziness and overwhelming waves of intense fear. These are some of the sensations that people with panic disorder face in their everyday lives, with unsettling episodes that come on without notice or identifiable triggers. And lots of people live this way; according to the National Institute of Mental Health (NIMH), about 4.7% of adults in America deal with panic disorder at some point in their lives. Even more people — about 7% to 8% of U.S. adults — face post-traumatic stress disorder (PTSD) in their lifetimes. Making accessible treatment crucial. And new evidence shows that an at-home digital therapeutic (DTx) can provide much-needed care for folks with panic disorder and PTSD.»

«In a recent study that was conducted by the makers of the DTx Freespira, data shows that the FDA-cleared therapeutic helped significantly in reducing symptoms with a high rate of user adherence (around 75%) to the treatment. Over a four-week treatment period, about two-thirds of the 1,569 subjects with panic disorder and PTSD reported significant drops in the severity of their symptoms. The study had notably low dropout rates: 10% for panic disorder patients and 11% for those with PTSD. Among the patients who stuck with the program, the group with panic disorder had about a 65% positive response rate, while those with PTSD had a 75% rate.»

Article written by William McCleary



Health Care Insider